Scholtz & Company Has Raised By $1.85 Million Its Triangle Capital (TCAP) Holding; ENCOMPASS COMPLIANCE CORPORATION (ENCC) Shorts Down By 0.49%

June 19, 2017 - By Richard Conner

Scholtz & Company Llc increased Triangle Capital Corporation (TCAP) stake by 89.76% reported in 2016Q4 SEC filing. Scholtz & Company Llc acquired 103,050 shares as Triangle Capital Corporation (TCAP)’s stock declined 8.63%. The Scholtz & Company Llc holds 217,850 shares with $4.00 million value, up from 114,800 last quarter. Triangle Capital Corporation now has $838.71 million valuation. The stock declined 0.28% or $0.05 reaching $17.58 on the news. About 154,992 shares traded. Triangle Capital Corporation (NYSE:TCAP) has risen 2.36% since June 19, 2016 and is uptrending. It has underperformed by 14.34% the S&P500.

ENCOMPASS COMPLIANCE CORPORATION (OTCMKTS:ENCC) had a decrease of 0.49% in short interest. ENCC’s SI was 20,300 shares in June as released by FINRA. Its down 0.49% from 20,400 shares previously. It is 0.00% or $0 reaching $0.008 per share. It is down 0.00% since June 19, 2016 and is . It has underperformed by 16.70% the S&P500.

Among 12 analysts covering Triangle Capital (NYSE:TCAP), 8 have Buy rating, 0 Sell and 4 Hold. Therefore 67% are positive. Triangle Capital had 15 analyst reports since August 7, 2015 according to SRatingsIntel. The company was downgraded on Friday, August 7 by Deutsche Bank. Bank of America initiated the stock with “Buy” rating in Friday, January 6 report. Robert W. Baird downgraded the stock to “Neutral” rating in Monday, May 2 report. The rating was upgraded by Raymond James on Wednesday, June 29 to “Market Perform”. The rating was initiated by Hilliard Lyons with “Buy” on Wednesday, September 28. The firm has “Buy” rating given on Tuesday, May 10 by Jefferies. The stock has “Neutral” rating by Janney Capital on Wednesday, April 27. National Securities maintained the stock with “Buy” rating in Tuesday, April 11 report.

Investors sentiment decreased to 1.37 in 2016 Q4. Its down 0.24, from 1.61 in 2016Q3. It fall, as 13 investors sold TCAP shares while 22 reduced holdings. 13 funds opened positions while 35 raised stakes. 11.00 million shares or 12.67% more from 9.77 million shares in 2016Q3 were reported. Bb&T Lc reported 64,511 shares. Jolley Asset Ltd Liability Corp accumulated 2,340 shares. Susquehanna Interest Llp holds 0% of its portfolio in Triangle Capital Corporation (NYSE:TCAP) for 48,000 shares. Wells Fargo & Mn holds 0.01% or 1.16 million shares. Gemmer Asset Mngmt Llc owns 900 shares or 0.01% of their US portfolio. Creative Planning stated it has 0% in Triangle Capital Corporation (NYSE:TCAP). Bb&T Corporation has invested 0.01% in Triangle Capital Corporation (NYSE:TCAP). Howe & Rusling holds 0% of its portfolio in Triangle Capital Corporation (NYSE:TCAP) for 360 shares. Allen Invest Management Ltd Llc has invested 0.03% in Triangle Capital Corporation (NYSE:TCAP). Eagle Glob Advisors Limited Liability Com has invested 0.01% of its portfolio in Triangle Capital Corporation (NYSE:TCAP). Janney Montgomery Scott Lc owns 114,347 shares. Commonwealth Equity Services holds 16,845 shares or 0% of its portfolio. 929,578 were reported by Price T Rowe Associate Md. Cwm Ltd Company accumulated 246 shares or 0% of the stock. Earnest Partners Lc accumulated 500 shares or 0% of the stock.

Encompass Compliance Corporation is engaged in providing workplace drug and alcohol testing compliance services. The company has market cap of $1.00 million. The Firm offers an annual subscription service, which maintains compliance and updates employers on the impact of the law, to their workplace. It currently has negative earnings. The Company’s services include statutes, regulations, court decisions and the Drug Testing Compliance Matrix, which provides the guidance for managing the rules that apply.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.



Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: